"PME the main competitor trades on 45x revenue."
You know there was a time when PME traded at LESS than 2 X Revenue! Despite being an established PROFITABLE company with a track record of paying consistent dividends.
M7T hasn't generated a cent of surplus capital and is trading at 15 X FY19 revenue!
If we are going to make that value comparison, at PME's lowest pricest point (at which stage of the company's growth, PME was generating nearly double the sales of M7T (and also generating FCF and paying almost 10% of it's share price in dividends):
then M7T would need to trade down to 7 CENTS.
Ann: Client Outlook Acquisition and Capital Raise Presentation, page-28
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add M7T (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.5¢ |
Change
0.005(0.91%) |
Mkt cap ! $133.8M | |||
| Open | High | Low | Value | Volume |
| 54.0¢ | 55.5¢ | 54.0¢ | $8.255K | 15.05K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2500 | 54.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 20901 | 1 |
View Market Depth
| Last trade - 15.20pm 30/09/2024 (20 minute delay) ? |
| M7T (ASX) Chart |